Bml-210
HDAC inhibitor
Product Specifications
Background
A novel non-hydroxamic acid HDAC inhibitor. IC50=5-10 µM (HeLa nuclear extract). Induces growth inhibition, proapoptotic and differentiation effects on human leukemia cell lines.
CAS Number
537034-17-6
Product Name Alternative
N1- (2-aminophenyl) -N8-phenyloctanediamide
UNSPSC
41116105
Type
Inhibitor
Source
Synthetic
Field of Research
Cell Signaling | Epigenetics and Nuclear Signaling | Cancer
Purity
>98% (TLC), NMR conforms
Weight
0.025
Format
Tan Solid
Solubility
Soluble in 25 mg/ml DMSO or 10 mg/ml Ethanol
Molecular Formula
C20H25N3O2
Molecular Weight
339.4
Precautions
Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.
References & Citations
1. Savickiene J., et al. (2006) Eur. J. Pharmacol. 549: 9. 2. Herman D., et al. (2006) Nature Chem. Biol. 10: 551.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC682314-500 1x 500 µL
P40 (deltaNp63) (Squamous, Basal & Myoepithelial Cell Marker), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
TRC-C428048-50MG 50 mg
4-Chlorothiophen-2-boronic acid, pinacol ester
Sign In for Pricing
View Details